Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide
Authors:
- Fran EnderlinFEFran Enderlin
- Barbara WallnerBWBarbara Wallner
- Dawn E SmilekDSDawn E Smilek
- 1 May 1997
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 75 (1-2) , 169-173
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic proteinNature, 1996
- A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cellsEuropean Journal of Immunology, 1995
- Immunological Aspects of Experimental Allergic Encephalomyelitis and Multiple SclerosisCritical Reviews in Clinical Laboratory Sciences, 1995
- Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.Journal of Experimental Medicine, 1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous systemEuropean Journal of Immunology, 1993
- Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamilyJournal of Neuroscience Research, 1992
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- The T Lymphocyte in Experimental Allergic EncephalomyelitisAnnual Review of Immunology, 1990
- A novel myelin-associated glycoprotein defined by a mouse monoclonal antibodyJournal of Neuroimmunology, 1984